Skip to main content
. 2020 Oct 13;21:266. doi: 10.1186/s12931-020-01526-6

Fig. 2.

Fig. 2

Overview of ongoing phase 2 and phase 3 clinical studies of tezepelumab. ACQ, Asthma Control Questionnaire; BD, bronchodilator; EOS, blood eosinophils; FEV1, forced expiratory volume in 1 s; HRQoL, health-related quality of life; ICS, inhaled corticosteroids; LTE, long-term extension; N, number of patients; OCS, oral corticosteroids; Q4W, every 4 weeks; RBM, reticular basement membrane; SC, subcutaneously; T2, type 2